In house or mutual R&D research programmes

IO SUMMIT London 2019

Poster – Oncodesign

We are very pleased to share our expertise in the Development of Pre-Clinical Assays to Support Drug Discovery Programs in Immuno-Oncology.

Find below the abstract that depicts our solution in immuno-oncology.

%MCEPASTEBIN%

Development of Pre-clinical Assays to support drug discovery programs in Immuno-Oncology

AuthorsV. Blancheteau1, C. Mignard1, D. Grillot1, V. Sart1, M. Vuibert1, A. Pinet1, G. Serin1, J-F. Mirjolet1, J. Caradec1
1Oncodesign, Dijon, France

The use of immunotherapies in oncology has drastically changed the way of treating cancer, providing innovative and efficient therapeutic solutions to patients in medical needs. As a consequence, tremendous R&D efforts are done in immuno-oncology to discover new targets and develop new drugs. In that context, the use of relevant and robust assays to predict therapeutic efficiencies has become a key for drug discovery programs.

We have gathered our experience and scientific expertise in immune-oncology to develop and provide solutions to support your drug discovery projects in immune-oncology, from hit identification to candidate selection, on a stand-alone basis or through integrated drug discovery solutions.

Based on human immune material for in vitro/ex vivo phenotypic assays and on advanced preclinical models – syngeneic or humanized - for in vivo assays, our scientists help you to assess your compound efficiency in routine or customized assays in order to provide the most relevant biological environment.

Ask for your poster copy !

Fill in the form below!

IO Summit Poster Request

Invalid Input

Invalid Input

Invalid Input

your address is not a proper one. Please check.

Invalid Input